{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:46:17Z","timestamp":1790858777927,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,27]]},"DOI":"10.1097\/01.tp.0000203894.53714.27","type":"journal-article","created":{"date-parts":[[2006,3,27]],"date-time":"2006-03-27T06:16:49Z","timestamp":1143440209000},"page":"845-852","source":"Crossref","is-referenced-by-count":88,"title":["A Randomized Long-Term Trial of Tacrolimus\/Sirolimus versus Tacrolimums\/Mycophenolate versus Cyclosporine\/Sirolimus in Renal Transplantation: Three-Year Analysis"],"prefix":"10.1097","volume":"81","author":[{"given":"Gaetano","family":"Ciancio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Gaynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Kupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210129","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/01.TP.0000069831.76067.22","article-title":"Randomized trial of tacrolimus + mycophenolate mofetil or azathioprone versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.","volume":"75","author":"Gonwa","year":"2003","journal-title":"Transplantation"},{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.tp.0000167757.63922.42","article-title":"A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year.","volume":"80","author":"Mendez","year":"2005","journal-title":"Transplantation"},{"key":"R3-6-20210129","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00007890-200204150-00015","article-title":"Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.","volume":"73","author":"Ciancio","year":"2002","journal-title":"Transplantation"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Imrpoved graft survival after renal transplantation in the United States, 1988 to 1996.","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1056\/NEJM199408113310604","article-title":"Long-term efficacy and safety of cyclosporine in renal transplant recipients.","volume":"331","author":"Burke","year":"1994","journal-title":"N Engl J Med"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00007890-199908150-00011","article-title":"Mycophenolate mofetil in renal transplantation: 3-year results from the placebocontrolled trial.","volume":"68","year":"1999","journal-title":"Transplantation"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00007890-199503150-00002","article-title":"Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.","volume":"59","author":"Gregory","year":"1995","journal-title":"Transplantation"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1097\/00007890-199912270-00004","article-title":"Immunologic factors: the major risk for decreased long-term renal allograft survival.","volume":"68","author":"Humar","year":"1999","journal-title":"Transplantation"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000101290.20629.DC","article-title":"A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.","volume":"77","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.TP.0000101495.22734.07","article-title":"A randomized long-term trial of tacrolimus\/sirolimus versus tacrolimus\/mycophenolate mofetil versus cyclosporine (NEORAL)\/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.","volume":"77","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/00007890-200208270-00010","article-title":"Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.","volume":"74","author":"Ciancio","year":"2002","journal-title":"Transplantation"},{"key":"R14-6-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine.","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ki.1993.259","article-title":"International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.","volume":"44","author":"Solez","year":"1993","journal-title":"Kidney Int"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00007890-199903270-00016","article-title":"Transforming growth factor (TGF)-beta mimics and anti-TGF-beta antibody abrogates the in vivo effects of cyclosporine: demonstration of a direct role of TGF-beta in immunosuppression and nephrotoxicity of cyclosporine.","volume":"67","author":"Khanna","year":"1999","journal-title":"Transplantation"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00007890-199902270-00021","article-title":"Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells.","volume":"67","author":"Khanna","year":"1999","journal-title":"Transplantation"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1097\/00007890-199812270-00029","article-title":"Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group.","volume":"66","author":"Solez","year":"1998","journal-title":"Transplantation"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/j.1600-6143.2004.00624.x","article-title":"Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival.","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am J Transplant"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.00052.x","article-title":"Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation.","volume":"18","author":"Oberbauer","year":"2005","journal-title":"Transpl Int"},{"key":"R21-6-20210129","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2004-0921","article-title":"Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.","volume":"146","author":"Khamzina","year":"2005","journal-title":"Endrocrinology"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1034\/j.1600-6143.2003.00181.x","article-title":"The use of daclizumab, tacrolimus and mycophenolate mofetil in African-American and Hispanic first renal transplant recipients.","volume":"3","author":"Ciancio","year":"2003","journal-title":"Am J Transplant"},{"key":"R23-6-20210129","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1194\/jlr.M100392-JLR200","article-title":"Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.","volume":"43","author":"Morrisett","year":"2002","journal-title":"J Lipid Res"},{"key":"R24-6-20210129","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1681\/ASN.V71158","article-title":"Cardiovascular disease after renal transplantation.","volume":"7","author":"Kasiske","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R25-6-20210129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00007890-199801150-00017","article-title":"Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study.","volume":"65","author":"McCune","year":"1998","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200603270-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:26:15Z","timestamp":1785857175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200603270-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,27]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000203894.53714.27","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3,27]]}}}